Works matching DE "FIBROLAMELLAR hepatocellular carcinoma"

Results: 109
    1
    2
    3

    Clinicopathological indices to predict hepatocellular carcinoma molecular classification.

    Published in:
    Liver International, 2016, v. 36, n. 1, p. 108, doi. 10.1111/liv.12889
    By:
    • Tan, Poh Seng;
    • Nakagawa, Shigeki;
    • Goossens, Nicolas;
    • Venkatesh, Anu;
    • Huang, Tiangui;
    • Ward, Stephen C.;
    • Sun, Xiaochen;
    • Song, Won ‐ Min;
    • Koh, Anna;
    • Canasto ‐ Chibuque, Claudia;
    • Deshmukh, Manjeet;
    • Nair, Venugopalan;
    • Mahajan, Milind;
    • Zhang, Bin;
    • Fiel, Maria Isabel;
    • Kobayashi, Masahiro;
    • Kumada, Hiromitsu;
    • Hoshida, Yujin
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas.

    Published in:
    Case Reports in Gastroenterology, 2015, v. 9, n. 2, p. 266, doi. 10.1159/000437290
    By:
    • Villa, Nicolas a.;
    • Pannala, Rahul;
    • Faigel, Douglas O.;
    • Haakinson, Danielle J.;
    • Katariya, Nitin;
    • Ramanathan, Ramesh;
    • Jaroszewski, Dawn;
    • Lidner, Thomas K.;
    • Byrne, Thomas
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Circulating CD147 predicts mortality in advanced hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 2, p. 459, doi. 10.1111/jgh.13148
    By:
    • Lee, Aimei;
    • Rode, Anthony;
    • Nicoll, Amanda;
    • Maczurek, Annette E;
    • Lim, Lucy;
    • Lim, Seok;
    • Angus, Peter;
    • Kronborg, Ian;
    • Arachchi, Niranjan;
    • Gorelik, Alexandra;
    • Liew, Danny;
    • Warner, Fiona J;
    • McCaughan, Geoffrey W;
    • McLennan, Susan V;
    • Shackel, Nicholas A
    Publication type:
    Article
    42
    43
    44

    The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33746-3
    By:
    • Bauer, Jens;
    • Köhler, Natalie;
    • Maringer, Yacine;
    • Bucher, Philip;
    • Bilich, Tatjana;
    • Zwick, Melissa;
    • Dicks, Severin;
    • Nelde, Annika;
    • Dubbelaar, Marissa;
    • Scheid, Jonas;
    • Wacker, Marcel;
    • Heitmann, Jonas S.;
    • Schroeder, Sarah;
    • Rieth, Jonas;
    • Denk, Monika;
    • Richter, Marion;
    • Klein, Reinhild;
    • Bonzheim, Irina;
    • Luibrand, Julia;
    • Holzer, Ursula
    Publication type:
    Article
    45

    In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease.

    Published in:
    Science Translational Medicine, 2017, v. 9, n. 399, p. 1, doi. 10.1126/scitranslmed.aah5505
    By:
    • Stevens, Kelly R.;
    • Scull, Margaret A.;
    • Ramanan, Vyas;
    • Fortin, Chelsea L.;
    • Chaturvedi, Ritika R.;
    • Knouse, Kristin A.;
    • Xiao, Jing W.;
    • Canny Fung;
    • Mirabella, Teodelinda;
    • Chen, Amanda X.;
    • McCue, Margaret G.;
    • Yang, Michael T.;
    • Fleming, Heather E.;
    • Kwanghun Chung;
    • de Jong, Ype P.;
    • Chen, Christopher S.;
    • Rice, Charles M.;
    • Bhatia, Sangeeta N.
    Publication type:
    Article
    46
    47
    48
    49
    50